154 related articles for article (PubMed ID: 23973877)
1. Cytotoxic activity of ex-vivo generated IFNα-induced monocyte-derived dendritic cells in brain glioma patients.
Tyrinova TV; Leplina OY; Mishinov SV; Tikhonova MA; Shevela EY; Stupak VV; Pendyurin IV; Shilov AG; Alyamkina EA; Rubtsova NV; Bogachev SS; Ostanin AA; Chernykh ER
Cell Immunol; 2013; 284(1-2):146-53. PubMed ID: 23973877
[TBL] [Abstract][Full Text] [Related]
2. Interferon alpha induces generation of semi-mature dendritic cells with high pro-inflammatory and cytotoxic potential.
Leplina OY; Tyrinova TV; Tikhonova MA; Ostanin AA; Chernykh ER
Cytokine; 2015 Jan; 71(1):1-7. PubMed ID: 25174880
[TBL] [Abstract][Full Text] [Related]
3. Defective Dendritic Cell Cytotoxic Activity of High-Grade Glioma Patients' Results from the Low Expression of Membrane TNFα and Can Be Corrected In Vitro by Treatment with Recombinant IL-2 or Exogenic Double-Stranded DNA.
Tyrinova T; Leplina O; Mishinov S; Tikhonova M; Kalinovskiy A; Chernov S; Dolgova E; Stupak V; Voronina E; Bogachev S; Shevela E; Ostanin A; Chernykh E
J Interferon Cytokine Res; 2018 Jul; 38(7):298-310. PubMed ID: 29932796
[TBL] [Abstract][Full Text] [Related]
4. Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response.
Tsugawa T; Kuwashima N; Sato H; Fellows-Mayle WK; Dusak JE; Okada K; Papworth GD; Watkins SC; Gambotto A; Yoshida J; Pollack IF; Okada H
Gene Ther; 2004 Nov; 11(21):1551-8. PubMed ID: 15343358
[TBL] [Abstract][Full Text] [Related]
5. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
6. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
7. Defective Regulation of Membrane TNFα Expression in Dendritic Cells of Glioblastoma Patients Leads to the Impairment of Cytotoxic Activity against Autologous Tumor Cells.
Tyrinova T; Leplina O; Mishinov S; Tikhonova M; Dolgova E; Proskurina A; Stupack V; Bogachev S; Ostanin A; Chernykh E
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326230
[TBL] [Abstract][Full Text] [Related]
8. An experimental study of dendritic cells-mediated immunotherapy against intracranial gliomas in rats.
Zhu X; Lu C; Xiao B; Qiao J; Sun Y
J Neurooncol; 2005 Aug; 74(1):9-17. PubMed ID: 16078102
[TBL] [Abstract][Full Text] [Related]
9. A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma.
Chang CN; Huang YC; Yang DM; Kikuta K; Wei KJ; Kubota T; Yang WK
J Clin Neurosci; 2011 Aug; 18(8):1048-54. PubMed ID: 21715171
[TBL] [Abstract][Full Text] [Related]
10. Delivery of interferon-alpha transfected dendritic cells into central nervous system tumors enhances the antitumor efficacy of peripheral peptide-based vaccines.
Okada H; Tsugawa T; Sato H; Kuwashima N; Gambotto A; Okada K; Dusak JE; Fellows-Mayle WK; Papworth GD; Watkins SC; Chambers WH; Potter DM; Storkus WJ; Pollack IF
Cancer Res; 2004 Aug; 64(16):5830-8. PubMed ID: 15313927
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumoral capabilities of effector cells after IFN-alpha or CpG-motif treatment of cocultured dendritic cells.
Erhardt M; Schmidt-Wolf IG; Sievers E; Frank S; Strehl J; von Lilienfeld-Toal M; Gorschlüter M
Arch Immunol Ther Exp (Warsz); 2006; 54(6):403-9. PubMed ID: 17122879
[TBL] [Abstract][Full Text] [Related]
12. IFN-α boosts epitope cross-presentation by dendritic cells via modulation of proteasome activity.
Lattanzi L; Rozera C; Marescotti D; D'Agostino G; Santodonato L; Cellini S; Belardelli F; Gavioli R; Ferrantini M
Immunobiology; 2011 May; 216(5):537-47. PubMed ID: 21093097
[TBL] [Abstract][Full Text] [Related]
13. [Dendritic cell therapy for malignant glioma].
Yamanaka R; Homma J; Yajima N; Tsuchiya N; Tanaka R
No To Shinkei; 2003 Sep; 55(9):771-80. PubMed ID: 14571839
[TBL] [Abstract][Full Text] [Related]
14. Autologous natural killer cell therapy for human recurrent malignant glioma.
Ishikawa E; Tsuboi K; Saijo K; Harada H; Takano S; Nose T; Ohno T
Anticancer Res; 2004; 24(3b):1861-71. PubMed ID: 15274367
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
[TBL] [Abstract][Full Text] [Related]
16. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.
Yamamoto T; Nagano H; Sakon M; Wada H; Eguchi H; Kondo M; Damdinsuren B; Ota H; Nakamura M; Wada H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Yagita H; Monden M
Clin Cancer Res; 2004 Dec; 10(23):7884-95. PubMed ID: 15585621
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma.
Yu JS; Liu G; Ying H; Yong WH; Black KL; Wheeler CJ
Cancer Res; 2004 Jul; 64(14):4973-9. PubMed ID: 15256471
[TBL] [Abstract][Full Text] [Related]
18. Interferon-α-inducible Dendritic Cells Matured with OK-432 Exhibit TRAIL and Fas Ligand Pathway-mediated Killer Activity.
Koya T; Yanagisawa R; Higuchi Y; Sano K; Shimodaira S
Sci Rep; 2017 Feb; 7():42145. PubMed ID: 28191816
[TBL] [Abstract][Full Text] [Related]
19. Synergism between cryoablation and GM-CSF: enhanced immune function of splenic dendritic cells in mice with glioma.
Xu H; Wang Q; Lin C; Yin Z; He X; Pan J; Lu G; Zhang S
Neuroreport; 2015 Apr; 26(6):346-53. PubMed ID: 25735009
[TBL] [Abstract][Full Text] [Related]
20. Engagement of human monocyte-derived dendritic cells into interleukin (IL)-12 producers by IL-1beta + interferon (IFN)-gamma.
Nakahara T; Urabe K; Fukagawa S; Uchi H; Inaba K; Furue M; Moroi Y
Clin Exp Immunol; 2005 Mar; 139(3):476-82. PubMed ID: 15730393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]